Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

✍ Scribed by Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolomeo, M.; Mazier, M.-A.; Canon, J.-L.; Georgoulias, V.; Peeters, M.; Bridgewater, J.; Cunningham, D.

• Book ID: 121677508
• Publisher: Oxford University Press
• Year: 2009
• Tongue: English
• Weight: 201 KB
• Volume: 20
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdp233